Ultragenyx Pharmaceutical, Inc. (RARE)
22.12
+0.70
(+3.27%)
USD |
NASDAQ |
Apr 02, 14:06
Ultragenyx Pharmaceutical Research and Development Expense (TTM) : 714.72M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 254.91M |
| Johnson & Johnson | 14.72B |
| CorMedix, Inc. | 19.33M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Insmed, Inc. | 771.09M |